EXCELSIOR MEDICAL LLC 10ML IN A 10ML SYRINGE, NACL 0.9%; 0.9% SODIUM CHLORIDE INJECTION, USP
|
Back to Search Results |
|
Model Number 1011-240 |
Device Problem
Device Operates Differently Than Expected (2913)
|
Patient Problem
Burning Sensation (2146)
|
Event Date 03/10/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
The syringe related to this complaint has not been returned, therefore an evaluation could not be performed.Although the original sample was not returned, samples from the same lot were obtained from the user facility.These samples along with retention samples, obtained from the manufacturing facility for the lot in question, were tested to determine if the fluid is consistent with product labeling.The results of the testing showed that both sample sets contained 0.9% sodium chloride, within the specified range indicated on the product labeling.At this time however, no conclusion or root cause can be provided as the investigation into this event is still being performed.Additionally, device history records for this lot were reviewed and no similar instances were found.A follow-up report will be submitted once the investigation is complete.
|
|
Event Description
|
Customer reported that a patient felt a burning sensation in their arm when the saline was pushed in.The syringe was not returned for evaluation.
|
|
Manufacturer Narrative
|
The investigation into this incident has been completed and it was determined that the most likely root cause was alcohol contamination during administration of therapy.The customer retained the two saline syringes used on the patient and performed testing to determine if any contaminants were present within the 0.9% saline solution; the results showed trace amounts of ethanol and propanol.As the origin of the ethanol and propanol was unknown, testing of unopened syringes from the same lot (#3126312) was performed to determine if contamination existed within other syringes; no evidence of ethanol or propanol was found.In order to provide further evidence, excelsior medical duplicated the testing performed by the customer on unopened retention samples from lot#3126312.Test results also showed no evidence of ethanol or propanol.Investigation was performed to determine the potential source of the alcohol contamination, and it was determined that it could not have occurred at the manufacturing facility as excelsior medical uses a closed system within a cleanroom environment to fill and cap syringes.This system does not allow for the introduction of any outside contaminants as the syringe is filled and the fluid path sealed prior to exiting the system.Additionally, saline lots are received in sealed bags with certificates of compliance, certifying that they contain proper levels of 0.9% sodium chloride per ups requirements.In contrast, hospital and patient care typically involves the use of alcohol based products for the purposes of personal hygiene, prepping of surgical areas and intravenous medication.As a result, the chances of contaminating a syringe tip or patient injection site with alcohol in a hospital environment is high.Therefore it has been concluded, based on the tests performed and the review of potential areas of contamination that the introduction of alcohol most likely occurred at the customer facility during the administration of therapy.In order to determine the potential impact that this alcohol contamination could have on the patient, two separate clinical evaluations were performed (see attachments).These evaluations concluded that the level of alcohol found during testing was at a level which posed no risk to the patient and were found to be approximately 1000 times lower than what could be found in a common nutritional intravenous solution.Based on the results of this investigation and the clinical assessments performed, this matter has been closed with no further action being required.(b)(4).
|
|
Search Alerts/Recalls
|
|
|